Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Digital Pathology Application Released for iPad and iPhone

By LabMedica International staff writers
Posted on 06 Jul 2011
A digital pathology viewing application with built-in educational content from institutes and pathologists was released for iPad and iPhone. More...


Users can try Digital Pathology for free and view, zoom and navigate digital slides through the high performance viewer. Existing Digital Image Hub users can connect the application to their own server to explore and view images from their own image collection.
SlidePath Gateway provides access to high quality whole slide images captured on the Leica Microsystems (Wetzlar, Germany) SCN400 slide scanner, with expert review findings and content provided by contributing bodies including the American Society for Clinical Pathology (ASCP) CheckPath Anatomical Pathology External Quality Assessment (EQA) Program (2006), Cerviva Cervical Cytology EQA Pilot (2009), National health Service (NHS) Breast Screening Pathology EQA Program (2010), UK National Urologic Pathology EQA Program (2009), and the United Kingdom National External Quality Assessment Service (UKNEQAS) HER2 Breast Interpretive EQA Pilot (2011).

Browsing folders of images from each of the EQA programs is possible. Individual cases can be selected and the user can view, zoom, and navigate around the slides. Each case includes expert pathologist assessments, which can be viewed with the slides, giving increased insight into the samples. They can also see a sample set of Leica Biosystems’ Novocastra antibody range.

Leica Microsystems’ Biosystems Division, also known as Leica Biosystems, offers histopathology laboratories a large product range with appropriate products for each work step in histology and for a high level of productivity in the working processes of the entire laboratory.

Dr. Donal O’Shea, Head of Digital Pathology in Leica Microsystems said, “The release of the SlidePath Gateway App displays Leica Microsystems’ commitment to develop and expand its Digital Pathology portfolio. With this App we are giving everyone the opportunity to try Digital Pathology, access high resolution whole slide images and expert opinions, through a highly intuitive user interface. With the rapid adoption and acceptance of iPads and other tablet devices in hospitals and clinical settings, we see SlidePath Gateway paving the way for future adoption of Digital Pathology in routine use.”

Related Links:

Leica Microsystems


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.